Sanofi is acquiring Vigil Neuroscience for $470 million to expand its Alzheimer’...
Gilead Sciences has acquired exclusive ownership of two arenavirus-based immunot...
The Food and Drug Administration (FDA) has introduced more rigorous regulatory r...
Boehringer Ingelheim’s presentation of phase 3 data for its idiopathic pulmonary...
CellCentric, a UK-based biotechnology company backed by Pfizer, has raised $120 ...
In a major breakthrough, researchers have uncovered a potential way to stop canc...
Moderna has announced that it is withdrawing its application for approval from t...
Pathos AI, a clinical-stage biotech company leveraging artificial intelligence t...
The U.S. Food and Drug Administration (FDA) has postponed its decision on Biohav...
The U.S. Food and Drug Administration has approved the first at-home collection ...
Eli Lilly is deepening its investment in Indiana by committing up to $250 millio...
Following similar actions by France and the European Union, U.S. health authorit...
Abeona Therapeutics has secured a $155 million deal from the sale of a Priority ...
Johnson & Johnson acquired the entire rights to a gene treatment for a rare cond...
Immutep, the developer of eftilagimod alpha, has reported promising overall surv...
Just four months after announcing a research collaboration, Eli Lilly is licensi...
